These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

297 related articles for article (PubMed ID: 23842280)

  • 1. Testosterone and the cardiovascular system: a comprehensive review of the basic science literature.
    Herring MJ; Oskui PM; Hale SL; Kloner RA
    J Am Heart Assoc; 2013 Jul; 2(4):e000271. PubMed ID: 23842280
    [No Abstract]   [Full Text] [Related]  

  • 2. Vascular Pathways of Testosterone: Clinical Implications.
    Lorigo M; Mariana M; Oliveira N; Lemos MC; Cairrao E
    J Cardiovasc Transl Res; 2020 Feb; 13(1):55-72. PubMed ID: 31820333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testosterone and the cardiovascular system: a comprehensive review of the clinical literature.
    Oskui PM; French WJ; Herring MJ; Mayeda GS; Burstein S; Kloner RA
    J Am Heart Assoc; 2013 Nov; 2(6):e000272. PubMed ID: 24242682
    [No Abstract]   [Full Text] [Related]  

  • 4. Reactive oxygen species: players in the cardiovascular effects of testosterone.
    Tostes RC; Carneiro FS; Carvalho MH; Reckelhoff JF
    Am J Physiol Regul Integr Comp Physiol; 2016 Jan; 310(1):R1-14. PubMed ID: 26538238
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel Beneficial Cardiovascular Effects of Natural Activators of Autophagy.
    Frati G; Vecchione C; Sciarretta S
    Circ Res; 2018 Sep; 123(8):947-949. PubMed ID: 30355035
    [No Abstract]   [Full Text] [Related]  

  • 6. Cardiovascular effects of sphingosine-1-phosphate (S1P).
    Levkau B
    Handb Exp Pharmacol; 2013; (216):147-70. PubMed ID: 23563656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leptin and the cardiovascular system - a target for therapeutic interventions.
    Beltowski J
    Curr Pharm Des; 2014; 20(4):601-2. PubMed ID: 23688018
    [No Abstract]   [Full Text] [Related]  

  • 8. Late-onset hypogonadism: Reductio ad absurdum of the cardiovascular risk-benefit of testosterone replacement therapy.
    Sesti F; Pofi R; Minnetti M; Tenuta M; Gianfrilli D; Isidori AM
    Andrology; 2020 Nov; 8(6):1614-1627. PubMed ID: 32737921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Future of Cardiovascular Therapeutics.
    MacRae CA; Roden DM; Loscalzo J
    Circulation; 2016 Jun; 133(25):2610-7. PubMed ID: 27324356
    [No Abstract]   [Full Text] [Related]  

  • 10. Vitamin D and its effects on cardiovascular diseases: a comprehensive review.
    Pérez-Hernández N; Aptilon-Duque G; Nostroza-Hernández MC; Vargas-Alarcón G; Rodríguez-Pérez JM; Blachman-Braun R
    Korean J Intern Med; 2016 Nov; 31(6):1018-1029. PubMed ID: 27117316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II- and Alzheimer-Type Cardiovascular Aging.
    Cooper HA; Scalia R; Rizzo V; Eguchi S
    Circ Res; 2018 Aug; 123(6):651-653. PubMed ID: 30355238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGMP Signaling in Cardiovascular Diseases: Linking Genotype and Phenotype.
    Dang TA; Schunkert H; Kessler T
    J Cardiovasc Pharmacol; 2020 Jun; 75(6):516-525. PubMed ID: 32487847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of neuregulin-1 in cardiovascular disease.
    Mendes-Ferreira P; De Keulenaer GW; Leite-Moreira AF; Brás-Silva C
    Drug Discov Today; 2013 Sep; 18(17-18):836-42. PubMed ID: 23384772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin and cardiovascular diseases: Focus on cellular targets and cascades.
    Pourbagher-Shahri AM; Farkhondeh T; Ashrafizadeh M; Talebi M; Samargahndian S
    Biomed Pharmacother; 2021 Apr; 136():111214. PubMed ID: 33450488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activating transcription factor 3 in cardiovascular diseases: a potential therapeutic target.
    Zhou H; Li N; Yuan Y; Jin YG; Guo H; Deng W; Tang QZ
    Basic Res Cardiol; 2018 Aug; 113(5):37. PubMed ID: 30094473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Testosterone and the Heart.
    Goodale T; Sadhu A; Petak S; Robbins R
    Methodist Debakey Cardiovasc J; 2017; 13(2):68-72. PubMed ID: 28740585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mineralocorticoid Receptor and Cardiovascular Disease.
    Buonafine M; Bonnard B; Jaisser F
    Am J Hypertens; 2018 Oct; 31(11):1165-1174. PubMed ID: 30192914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydrogen Sulfide Switch Phenomenon Regulating Autophagy in Cardiovascular Diseases.
    Luo W; Gui DD; Yan BJ; Ren Z; Peng LJ; Wei DH; Liu LS; Zhang DW; Jiang ZS
    Cardiovasc Drugs Ther; 2020 Feb; 34(1):113-121. PubMed ID: 32090295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Roles for Adipose Tissue in Cardiovascular Disease.
    Ha EE; Bauer RC
    Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):e137-e144. PubMed ID: 30354196
    [No Abstract]   [Full Text] [Related]  

  • 20. The Pivotal Role of Mitsugumin 53 in Cardiovascular Diseases.
    Jiang W; Liu M; Gu C; Ma H
    Cardiovasc Toxicol; 2021 Jan; 21(1):2-11. PubMed ID: 33006052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.